Works matching IS 22351795 AND DT 2024 AND VI 13 AND IP 1

Results: 9

Front & Back Matter.

Published in:: Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 1, doi. 10.1159/000537766
Publication type:: Article

Objective Response to Systemic Therapy Is a Strong Predictor of Overall Survival in Patients with Unresectable Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 1, doi. 10.1159/000535516

By:

Kudo, Masatoshi

Publication type:

Article

A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 99, doi. 10.1159/000531377

By:

Kudo, Masatoshi;
Ueshima, Kazuomi;
Saeki, Issei;
Ishikawa, Toru;
Inaba, Yoshitaka;
Morimoto, Naoki;
Aikata, Hiroshi;
Tanabe, Nobukazu;
Wada, Yoshiyuki;
Kondo, Yasuteru;
Tsuda, Masahiro;
Nakao, Kazuhiko;
Ito, Takanori;
Hosaka, Tetsuya;
Kawamura, Yusuke;
Kuzuya, Teiji;
Nojiri, Shunsuke;
Ogawa, Chikara;
Koga, Hironori;
Hino, Keisuke

Publication type:

Article

Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 89, doi. 10.1159/000531182

By:

Song, Young Shin;
Yang, Hannah;
Kang, Beodeul;
Cheon, Jaekyung;
Kim, Ilhwan;
Kim, Hyeyeong;
Lee, Won Suk;
Sang, Yun Beom;
Jung, Sanghoon;
Lim, Ho Yeong;
Gaillard, Vincent E.;
Kim, Chan;
Chon, Hong Jae

Publication type:

Article

Multimodal Integrative Genomics and Pathology Analyses in Neoadjuvant Nivolumab Treatment for Intermediate and Locally Advanced Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 70, doi. 10.1159/000531176

By:

Cheung, Tan-To;
Ho, Daniel Wai-Hung;
Lyu, Shirley Xueying;
Zhang, Qingyang;
Tsui, Yu-Man;
Yu, Tiffany Ching-Yun;
Sze, Karen Man-Fong;
Lee, Joyce Man-Fong;
Lau, Vince Wing-hang;
Chu, Edward Yin-Lun;
Tsang, Simon Hing-Yin;
She, Wong-Hoi;
Leung, Roland Ching-Yu;
Yau, Thomas Chung-Cheung;
Ng, Irene Oi-Lin

Publication type:

Article

Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 56, doi. 10.1159/000531024

By:

Aoki, Tomoko;
Kudo, Masatoshi;
Ueshima, Kazuomi;
Morita, Masahiro;
Chishina, Hirokazu;
Takita, Masahiro;
Hagiwara, Satoru;
Ida, Hiroshi;
Minami, Yasunori;
Tsurusaki, Masakatsu;
Nishida, Naoshi

Publication type:

Article

Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 29, doi. 10.1159/000530950

By:

Hung, Ya-Wen;
Lee, I-Cheng;
Chi, Chen-Ta;
Lee, Rheun-Chuan;
Liu, Chien-An;
Chiu, Nai-Chi;
Hwang, Hsuen-En;
Chao, Yee;
Hou, Ming-Chih;
Huang, Yi-Hsiang

Publication type:

Article

Combined Hepatocellular-Cholangiocarcinoma: Biology, Diagnosis, and Management.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 6, doi. 10.1159/000530700

By:

Ye, Liangtao;
Schneider, Julia S.;
Ben Khaled, Najib;
Schirmacher, Peter;
Seifert, Carolin;
Frey, Lea;
He, Yulong;
Geier, Andreas;
De Toni, Enrico N.;
Zhang, Changhua;
Reiter, Florian P.

Publication type:

Article

HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 1, p. 41, doi. 10.1159/000530699

By:

Li, Chiao-Ling;
Hsu, Chia-Lang;
Lin, You-Yu;
Ho, Ming-Chih;
Chen, Chi-Ling;
Ho, Tung-Ching;
Lin, Yung-Feng;
Tsai, Shih-Feng;
Tzeng, Sheng-Tai;
Huang, Chin-Fang;
Wang, Ya-Chun;
Yeh, Shiou-Hwei;
Chen, Pei-Jer

Publication type:

Article